Biocartis fixes IPO price at top end of range

April 20, 2015 1:32 PM

4 0

BRUSSELS, April 20 (Reuters) - Belgian molecular diagnosis company Biocartis Group NV has fixed the price for its upcoming flotation at the top of the indicated range, meaning it could raise as much as 115 million euros ($123.4 million) in new shares.

The company said in a statement on Monday that it would issue shares at 11.50 euros. It had previous given an indicative range of 10.00 to 11.50 euros.

Also read: Hotel-Search Firm Plans IPO of Up to $428 Million, Rename Itself Trivago

Read more

To category page

Loading...